Bladder Carcinoma — Trials

Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

332 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 141
Recruiting: 74
Ph III recruiting: 14
Growth YoY: +6.5%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 48.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (49)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02439060	PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)	completed	N/A	156	University of Southern CaliforniaOTHER	1	Apr 23, 2025	clinicaltrials
NCT06818799	Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer	completed	N/A	50	Helwan UniversityOTHER	1	Feb 12, 2025	clinicaltrials
NCT06789224